CRYOPORT, INC. Increase (Decrease) in Prepaid Expense and Other Assets
CRYOPORT, INC. (CYRX) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$2.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- CRYOPORT, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$589.00K.
- CRYOPORT, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$2.22M.
- CRYOPORT, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $3.17M, a 21.71% increase year-over-year.
- CRYOPORT, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$1.33M.
- CRYOPORT, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.35M, a 162.96% decline from fiscal 2024.
- CRYOPORT, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $2.15M, a 1986.41% increase from fiscal 2023.
- CRYOPORT, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $103.00K, a 93.55% decline from fiscal 2022.
- CRYOPORT, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $1.60M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$589.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.81M 10-Q · filed 2026-08-06 | $356.00K derived: sum of 3 quarters · filed 2026-08-06 | -$977.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$2.22M 10-Q · filed 2026-05-05 | $945.00K derived: sum of 2 quarters · filed 2026-05-05 | -$388.00K derived: sum of 3 quarters · filed 2026-05-05 | -$3.18M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.83M derived: sum of 2 quarters · filed 2026-03-05 | -$959.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.35M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | -$1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$4.13M derived: sum of 2 quarters · filed 2026-08-06 | -$4.52M 10-Q · filed 2025-11-06 | -$1.92M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$3.19M 10-Q · filed 2026-08-06 | -$585.00K derived: sum of 3 quarters · filed 2026-08-06 | -$2.42M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$394.00K 10-Q · filed 2026-05-05 | $2.21M derived: sum of 2 quarters · filed 2026-05-05 | $374.00K derived: sum of 3 quarters · filed 2026-05-05 | $581.00K derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $768.00K derived: sum of 2 quarters · filed 2026-03-05 | $975.00K derived: sum of 3 quarters · filed 2026-03-05 | $2.15M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | -$1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.63M derived: sum of 2 quarters · filed 2025-11-06 | -$454.00K 10-Q · filed 2025-11-06 | -$2.65M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-06-30 | $207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.38M 10-Q · filed 2025-08-12 | -$814.00K derived: sum of 3 quarters · filed 2026-03-05 | $2.73M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-03-31 | $1.17M 10-Q · filed 2025-05-08 | -$1.02M derived: sum of 2 quarters · filed 2026-03-05 | $2.53M derived: sum of 3 quarters · filed 2026-03-05 | $1.01M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2023-12-31 | -$2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.35M derived: sum of 2 quarters · filed 2026-03-05 | -$168.00K derived: sum of 3 quarters · filed 2026-03-05 | $103.00K 10-K · filed 2026-03-05 | ||||
| 2023-09-30 | $3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.03M derived: sum of 2 quarters · filed 2024-11-07 | $2.30M 10-Q · filed 2024-11-07 | $2.48M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.25M 10-Q · filed 2024-08-08 | -$1.07M derived: sum of 3 quarters · filed 2025-03-07 | -$696.00K derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | $271.00K 10-Q · filed 2024-05-08 | $450.00K derived: sum of 2 quarters · filed 2025-03-07 | $826.00K derived: sum of 3 quarters · filed 2025-03-07 | $1.89M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $555.00K derived: sum of 2 quarters · filed 2025-03-07 | $1.62M derived: sum of 3 quarters · filed 2025-03-07 | $1.60M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | $376.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.44M derived: sum of 2 quarters · filed 2023-11-09 | $1.42M 10-Q · filed 2023-11-09 | $1.08M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.04M 10-Q · filed 2023-08-09 | $709.00K derived: sum of 3 quarters · filed 2024-03-13 | -$2.52M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-03-31 | -$21.00K 10-Q · filed 2023-05-04 | -$355.00K derived: sum of 2 quarters · filed 2024-03-13 | -$3.59M derived: sum of 3 quarters · filed 2024-03-13 | -$9.62M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | -$334.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$3.57M derived: sum of 2 quarters · filed 2024-03-13 | -$9.60M derived: sum of 3 quarters · filed 2024-03-13 | -$3.06M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | -$3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$9.27M derived: sum of 2 quarters · filed 2022-11-04 | -$2.72M 10-Q · filed 2022-11-04 | $4.95M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$6.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $512.00K 10-Q · filed 2022-08-04 | $8.18M derived: sum of 3 quarters · filed 2023-02-28 | $8.24M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $6.54M 10-Q · filed 2022-05-05 | $14.22M derived: sum of 2 quarters · filed 2023-02-28 | $14.27M derived: sum of 3 quarters · filed 2023-02-28 | $14.16M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $7.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $7.72M derived: sum of 2 quarters · filed 2023-02-28 | $7.62M derived: sum of 3 quarters · filed 2023-02-28 | $7.52M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$56.00K derived: sum of 2 quarters · filed 2021-11-04 | -$151.00K 10-Q · filed 2021-11-04 | -$151.52K 10-Q · filed 2020-11-06 | -$9.74K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | -$110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$205.00K 10-Q · filed 2021-08-06 | -$205.20K 10-Q · filed 2020-08-10 | -$63.74K derived: sum of 3 quarters · filed 2022-02-28 | $365.40K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | -$95.00K 10-Q · filed 2021-05-06 | -$94.67K 10-Q · filed 2020-05-08 | $46.26K derived: sum of 2 quarters · filed 2022-02-28 | $475.40K derived: sum of 3 quarters · filed 2022-02-28 | $260.05K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $141.26K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $570.40K derived: sum of 2 quarters · filed 2022-02-28 | $355.05K derived: sum of 3 quarters · filed 2022-02-28 | $345.00K 10-K · filed 2022-02-28 | $344.59K 10-K · filed 2020-03-10 | |||
| 2019-09-30 | $429.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $213.78K derived: sum of 2 quarters · filed 2020-11-06 | $203.74K 10-Q · filed 2020-11-06 | $85.41K derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | -$215.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$225.40K 10-Q · filed 2020-08-10 | -$343.73K derived: sum of 3 quarters · filed 2020-08-10 | $35.79K derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$10.05K 10-Q · filed 2020-05-08 | -$128.38K derived: sum of 2 quarters · filed 2020-05-08 | $251.15K derived: sum of 3 quarters · filed 2020-05-08 | $200.74K derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | -$118.33K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $261.19K derived: sum of 2 quarters · filed 2020-03-10 | $210.79K derived: sum of 3 quarters · filed 2020-03-10 | $235.82K 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $379.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $329.12K derived: sum of 2 quarters · filed 2019-11-12 | $354.15K 10-Q · filed 2019-11-12 | $638.22K derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | -$50.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$25.37K 10-Q · filed 2019-08-09 | $258.70K derived: sum of 3 quarters · filed 2019-08-09 | $214.11K derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | $25.04K 10-Q · filed 2019-05-09 | $309.10K derived: sum of 2 quarters · filed 2019-05-09 | $264.51K derived: sum of 3 quarters · filed 2019-05-09 | $252.02K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $284.06K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $239.48K derived: sum of 2 quarters · filed 2019-03-13 | $226.99K derived: sum of 3 quarters · filed 2019-03-13 | $261.49K 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | -$44.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$57.08K derived: sum of 2 quarters · filed 2018-11-08 | -$22.58K 10-Q · filed 2018-11-08 | -$342.48K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | -$12.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $22.01K 10-Q · filed 2018-08-09 | -$297.89K derived: sum of 3 quarters · filed 2018-08-09 | $19.97K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $34.50K 10-Q · filed 2018-05-03 | -$285.40K derived: sum of 2 quarters · filed 2018-05-03 | $32.46K derived: sum of 3 quarters · filed 2018-05-03 | $72.69K derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2016-12-31 | -$319.90K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$2.04K derived: sum of 2 quarters · filed 2018-03-08 | $38.19K 10-K · filed 2018-03-08 | -$2.05K 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | $317.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $358.09K derived: sum of 2 quarters · filed 2017-11-02 | $317.86K 10-Q · filed 2017-11-02 | |||||
| 2016-06-30 | $40.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$10.00 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | -$40.24K 10-Q · filed 2017-05-04 | $151.39K 10-KT · filed 2017-03-13 | ||||||
| 2015-12-31 | $479.96K 10-KT · filed 2017-03-13 | |||||||
| 2015-03-31 | -$816.00 10-K · filed 2016-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |